DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
+6.89%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$53.9B
AUM Growth
-$1.63B
(-2.9%)
Cap. Flow
-$3.64B
Cap. Flow
% of AUM
-6.75%
Top 10 Holdings %
Top 10 Hldgs %
26.17%
Holding
1,489
New
41
Increased
394
Reduced
550
Closed
60
Top Buys
| 1 |
CVS Health
CVS
|
$78.6M |
| 2 |
Sysco
SYY
|
$55.4M |
| 3 |
Progressive
PGR
|
$44.2M |
| 4 |
Exxon Mobil
XOM
|
$42.4M |
| 5 |
Mondelez International
MDLZ
|
$27.4M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$1.67B |
| 2 |
Broadcom
AVGO
|
$1.19B |
| 3 |
Amazon
AMZN
|
$116M |
| 4 |
Canadian Natural Resources
CNQ
|
$74.1M |
| 5 |
Gilead Sciences
GILD
|
$66M |
Sector Composition
| 1 | Technology | 27.08% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 10.83% |
| 4 | Industrials | 10.14% |
| 5 | Consumer Discretionary | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
Reinsurance Group of America
RGA
$12.7B
| $1.59M | ﹤0.01% |
7,428
| – | – |
|
802
Clearway Energy Class C
CWEN
$3.34B
| $1.59M | ﹤0.01% |
52,299
-942
| -2% | -$28.5K |
|
803
AES
AES
$9.06B
| $1.58M | ﹤0.01% |
78,144
-28,872
| -27% | -$584K |
|
804
Apellis Pharmaceuticals
APLS
$3.4B
| $1.58M | ﹤0.01% |
55,000
| – | – |
|
805
Coupang
CPNG
$57.4B
| $1.56M | ﹤0.01% |
67,523
| – | – |
|
806
Core & Main
CNM
$12.6B
| $1.56M | ﹤0.01% |
27,276
+4,782
| +21% | +$273K |
|
807
ADMA Biologics
ADMA
$3.92B
| $1.55M | ﹤0.01% |
236,178
| – | – |
|
808
TFI International
TFII
$7.9B
| $1.55M | ﹤0.01% |
11,256
+241
| +2% | +$33.1K |
|
809
Intellia Therapeutics
NTLA
$1.27B
| $1.54M | ﹤0.01% |
75,000
| – | – |
|
810
IDEAYA Biosciences
IDYA
$2.05B
| $1.53M | ﹤0.01% |
50,000
| – | – |
|
811
Paycom
PAYC
$12.6B
| $1.53M | ﹤0.01% |
9,150
+3,208
| +54% | +$535K |
|
812
Erie Indemnity
ERIE
$17.6B
| $1.52M | ﹤0.01% |
2,783
+45
| +2% | +$24.6K |
|
813
Elastic
ESTC
$9.81B
| $1.52M | ﹤0.01% |
19,746
| – | – |
|
814
Acadia Pharmaceuticals
ACAD
$4.28B
| $1.51M | ﹤0.01% |
97,284
| – | – |
|
815
Xenon Pharmaceuticals
XENE
$2.94B
| $1.5M | ﹤0.01% |
39,000
| – | – |
|
816
SolarEdge
SEDG
$1.99B
| $1.5M | ﹤0.01% |
+66,000
| New | +$1.5M |
|
817
PPL Corp
PPL
$26.4B
| $1.49M | ﹤0.01% |
46,028
-1,657
| -3% | -$53.6K |
|
818
AngloGold Ashanti
AU
$31.4B
| $1.48M | ﹤0.01% |
53,477
+3,477
| +7% | +$96.4K |
|
819
Avidity Biosciences
RNA
$6.18B
| $1.48M | ﹤0.01% |
60,000
| – | – |
|
820
Liberty Media Series C
FWONK
$25.5B
| $1.48M | ﹤0.01% |
19,073
-8,054
| -30% | -$625K |
|
821
Murphy USA
MUSA
$7.56B
| $1.47M | ﹤0.01% |
2,952
+557
| +23% | +$277K |
|
822
Franklin Resources
BEN
$12.9B
| $1.47M | ﹤0.01% |
72,275
+15,688
| +28% | +$318K |
|
823
TechnipFMC
FTI
$16.1B
| $1.47M | ﹤0.01% |
58,000
| – | – |
|
824
Assurant
AIZ
$10.7B
| $1.46M | ﹤0.01% |
7,353
-1,787
| -20% | -$355K |
|
825
Dynatrace
DT
$15.1B
| $1.46M | ﹤0.01% |
31,729
-1,121
| -3% | -$51.4K |
|